Bismuth, whole blood-994

Test info

  
Bismuth, whole blood
  
994
  
LAB994
  
MSO
  

Monitor exposure to bismuth

Specimen

  
EDTA whole blood, metal free
  
  
7 mL
  
1.1 mL
  

Immediately following collection, mix sample thoroughly by gently inverting 8 - 10, times to prevent clotting

  

Navy blue metal free vial/tube with EDTA

  

Ambient (preferred) – 14 days

Refrigerated – 14 days

Frozen – 14 days

   Freeze/thaw cycles - stable x3

  
  • Clotted specimen

Performance

  
LabCorp (833854): R-NX
  
Mo - Fr
  
3 - 4 days
  

Inductively-coupled plasma/mass spectrometry (ICP/MS)

Clinical and Interpretive info

  

<10 μg/L

  

Bismuth poisoning through acute exposure is generally associated with the ingestion of soluble bismuth compounds as encountered in the therapeutic application of bismuth. Symptoms of acute poisoning often begin with foul breath and stomatitis and may progress to malaise, nausea, weight loss, and depression. Chronic bismuth exposure, which is typically attributed to inhalation, was generally evidenced by “tellurium breath,” but no adverse health effects were noted.

Bismuth is employed in the production of low-melting alloys. It is also added to steel and iron to produce castings that are more easily machined. Bismuth is widely employed in the manufacture of ceramics and glass. The primary US source of bismuth is as a byproduct of the refining of lead and copper ores. Bismuth applications outside of industry include certain over-the-counter drugs intended as aids for gastrointestinal disturbances, as well as the pearlescent white coloring matter used in some lipsticks, powders, and fingernail enamels.

Billing

  
83018
  
Yes
  

Tracking

  
02/23/2022
  
10/21/2024
  
06/06/2023